Fifth Third Bancorp Regeneron Pharmaceuticals, Inc. Transaction History

Fifth Third Bancorp

$27.3 Billion
Q3 2024

A detailed history of Fifth Third Bancorp transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Fifth Third Bancorp holds 10,396 shares of REGN stock, worth $7.45 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

10,396

Previous 8,253 25.97%

Holding current value

$7.45 Million

Previous $8.67 Million 25.99%

% of portfolio

0.04%

Previous 0.03%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	BUY	$1024.09 - $1201.76 $2.19 Million - $2.58 Million	2,143 Added 25.97%	10,396 $10.9 Million
Q2 2024 Jul 22, 2024	SELL	$883.2 - $1071.19 $105,100 - $127,471	-119 Reduced 1.42%	8,253 $8.67 Million
Q1 2024 Apr 23, 2024	SELL	$902.69 - $993.35 $216,645 - $238,404	-240 Reduced 2.79%	8,372 $8.06 Million
Q4 2023 Jan 19, 2024	SELL	$775.18 - $881.7 $48,061 - $54,665	-62 Reduced 0.71%	8,612 $7.56 Million
Q3 2023 Oct 31, 2023	BUY	$692.45 - $844.37 $9,001 - $10,976	13 Added 0.15%	8,674 $7.14 Million
Q2 2023 Jul 25, 2023	BUY	$700.03 - $830.35 $124,605 - $147,802	178 Added 2.1%	8,661 $6.22 Million
Q1 2023 Apr 24, 2023	SELL	$680.49 - $826.97 $202,105 - $245,610	-297 Reduced 3.38%	8,483 $6.97 Million
Q4 2022 Jan 25, 2023	BUY	$705.89 - $766.39 $33,176 - $36,020	47 Added 0.54%	8,780 $0
Q3 2022 Oct 25, 2022	BUY	$573.97 - $724.32 $110,202 - $139,069	192 Added 2.25%	8,733 $6.02 Million
Q2 2022 Aug 04, 2022	SELL	$548.35 - $738.84 $2.35 Million - $3.16 Million	-4,279 Reduced 33.38%	8,541 $5.05 Million
Q1 2022 Apr 19, 2022	SELL	$595.12 - $698.43 $200,555 - $235,370	-337 Reduced 2.56%	12,820 $8.95 Million
Q4 2021 Feb 01, 2022	BUY	$543.48 - $670.97 $378,805 - $467,666	697 Added 5.59%	13,157 $8.31 Million
Q3 2021 Oct 15, 2021	BUY	$574.03 - $680.96 $2.29 Million - $2.71 Million	3,983 Added 46.99%	12,460 $7.54 Million
Q2 2021 Aug 06, 2021	SELL	$472.8 - $558.54 $5.4 Million - $6.38 Million	-11,425 Reduced 57.41%	8,477 $4.74 Million
Q1 2021 May 07, 2021	SELL	$446.73 - $548.2 $1.55 Million - $1.9 Million	-3,460 Reduced 14.81%	19,902 $9.42 Million
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $1.42 Million - $1.8 Million	-2,965 Reduced 11.26%	23,362 $11.3 Million
Q3 2020 Nov 09, 2020	BUY	$544.75 - $658.21 $388,406 - $469,303	713 Added 2.78%	26,327 $14.7 Million
Q2 2020 Aug 05, 2020	BUY	$493.32 - $643.92 $3.8 Million - $4.97 Million	7,712 Added 43.08%	25,614 $16 Million
Q1 2020 May 05, 2020	SELL	$336.18 - $494.43 $6.16 Million - $9.06 Million	-18,317 Reduced 50.57%	17,902 $8.74 Million
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $167,767 - $230,424	612 Added 1.72%	36,219 $13.6 Million
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $6.37 Million - $7.42 Million	23,304 Added 189.42%	35,607 $9.88 Million
Q2 2019 Aug 07, 2019	BUY	$299.6 - $414.82 $3.54 Million - $4.9 Million	11,811 Added 2400.61%	12,303 $3.85 Million
Q1 2019 May 14, 2019	BUY	$372.08 - $439.57 $27,533 - $32,528	74 Added 17.7%	492 $202,000
Q4 2018 Feb 14, 2019	SELL	$335.82 - $403.04 $167,238 - $200,713	-498 Reduced 54.37%	418 $156,000
Q3 2018 Nov 14, 2018	BUY	$351.14 - $408.51 $34,411 - $40,033	98 Added 11.98%	916 $370,000
Q2 2018 Aug 14, 2018	SELL	$284.6 - $344.99 $16,222 - $19,664	-57 Reduced 6.51%	818 $282,000
Q1 2018 May 15, 2018	BUY	$315.82 - $393.78 $138,013 - $172,081	437 Added 99.77%	875 $301,000
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $24,745 - $32,426	69 Added 18.7%	438 $165,000
Q3 2017 Nov 14, 2017	SELL	$431.38 - $504.0 $5,176 - $6,048	-12 Reduced 3.15%	369 $165,000
Q2 2017 Aug 11, 2017	BUY	N/A	381	381 $187,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.8B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.

Account

Fifth Third Bancorp Regeneron Pharmaceuticals, Inc. Transaction History